Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -278,017 | -236,455 | -215,524 | -285,405 | -190,669 |
| Depreciation Amortization | 3,628 | 2,990 | 3,166 | 4,027 | 3,119 |
| Accounts receivable | N/A | 620 | 1,633 | -1,607 | 1,276 |
| Accounts payable and accrued liabilities | 3,658 | -4,274 | 3,575 | 3,796 | -16,436 |
| Other Working Capital | -37,777 | -45,400 | 59,429 | 22,431 | 46,928 |
| Other Operating Activity | 58,105 | 44,322 | 34,854 | 55,706 | 56,793 |
| Operating Cash Flow | $-250,403 | $-238,197 | $-112,867 | $-201,052 | $-98,989 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,942 | 0 | N/A | N/A | N/A |
| PPE Investments | -6,552 | -3,171 | -7,223 | -2,406 | -2,135 |
| Net Acquisitions | N/A | 5,000 | 20,000 | N/A | N/A |
| Purchase Of Investment | -401,987 | -423,898 | -183,261 | -288,791 | -237,567 |
| Sale Of Investment | 399,318 | 339,018 | 347,192 | 234,864 | 91,467 |
| Investing Cash Flow | $10,721 | $-83,051 | $176,708 | $-56,333 | $-148,235 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 380,000 | 0 | 229,441 | N/A | N/A |
| Debt Repayment | -235,347 | -2,152 | N/A | N/A | N/A |
| Common Stock Issued | 144,977 | 6,616 | 5,566 | 10,216 | 483,076 |
| Common Stock Repurchased | -9,749 | -3,173 | -9,807 | -8,560 | -3,871 |
| Other Financing Activity | -16,796 | 0 | 0 | 0 | 21 |
| Financing Cash Flow | $263,085 | $1,291 | $225,200 | $1,656 | $479,226 |
| Beginning Cash Position | 58,897 | 378,854 | 89,813 | 345,542 | 113,540 |
| End Cash Position | 82,300 | 58,897 | 378,854 | 89,813 | 345,542 |
| Net Cash Flow | $23,403 | $-319,957 | $289,041 | $-255,729 | $232,002 |
| Free Cash Flow | |||||
| Operating Cash Flow | -250,403 | -238,197 | -112,867 | -201,052 | -98,989 |
| Capital Expenditure | -6,616 | -3,176 | -7,240 | -2,406 | -2,135 |
| Free Cash Flow | -257,019 | -241,373 | -120,107 | -203,458 | -101,124 |